MARKET

AMPH

AMPH

Amphastar Pharma
NASDAQ
26.77
-0.38
-1.40%
After Hours: 26.77 0 0.00% 17:01 12/05 EST
OPEN
27.15
PREV CLOSE
27.15
HIGH
27.47
LOW
26.69
VOLUME
323.53K
TURNOVER
--
52 WEEK HIGH
46.11
52 WEEK LOW
20.39
MARKET CAP
1.23B
P/E (TTM)
11.87
1D
5D
1M
3M
1Y
5Y
1D
Can DefenCath Continue to Aid CorMedix's Long-Term Growth Ahead?
NASDAQ · 20h ago
Amphastar Pharmaceuticals (AMPH) Stock Trades Up, Here Is Why
Barchart · 2d ago
Weekly Report: what happened at AMPH last week (1124-1128)?
Weekly Report · 5d ago
Amphastar Pharmaceuticals (AMPH) Is Up 6.5% After Earnings Beat and Pipeline Expansion—What's Changed?
Simply Wall St · 6d ago
A Look at Amphastar Pharmaceuticals’s Valuation After Upbeat Earnings and Strategic Pipeline Moves (AMPH)
Simply Wall St · 11/29 02:22
Does Amphastar’s New Product Approvals Signal a Turning Point for the Stock in 2025?
Simply Wall St · 11/27 21:35
Amphastar Pharmaceuticals Director Richard K. Prins Reports Disposal of Common Shares
Reuters · 11/26 00:39
Amphastar Pharmaceuticals Executives to Join Analyst-Moderated Fireside Chat at Piper Sandler Healthcare Conference
Reuters · 11/24 11:00
More
About AMPH
Amphastar Pharmaceuticals, Inc. is a biopharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable, inhalation, and intranasal products. Additionally, it sells insulin API products. Most of its finished products are used in hospital or urgent care clinical settings and are primarily contracted and distributed through group purchasing organizations and drug wholesalers. The Company manufactures and sells over 25 products, such as BAQSIMI (glucagon) nasal powder 3mg, Primatene MIST, Glucagon for Injection Emergency Kit, Enoxaparin, Naloxone and Other Marketed Products, including Cortrosyn (cosyntropin for injection), Amphadase, Epinephrine injection, Lidocaine jelly, Lidocaine topical solution, Phytonadione injection, and others. The Company manufactures and sells two API products, Recombinant Human Insulin (RHI API) and porcine insulin API, for the injectable insulin market.

Webull offers Amphastar Pharmaceuticals Inc stock information, including NASDAQ: AMPH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMPH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AMPH stock methods without spending real money on the virtual paper trading platform.